Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 1
1972 2
1975 1
1978 1
1979 4
1980 1
1981 1
1984 1
1985 1
1986 2
1987 3
1988 3
1991 2
1992 5
1993 6
1994 6
1995 7
1996 7
1997 11
1998 15
1999 14
2000 19
2001 17
2002 15
2003 25
2004 40
2005 38
2006 48
2007 47
2008 42
2009 49
2010 40
2011 60
2012 64
2013 64
2014 77
2015 67
2016 72
2017 44
2018 63
2019 72
2020 67
2021 91
2022 96
2023 100
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

1,288 results

Results by year

Filters applied: . Clear all
Page 1
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection.
Cahn P, Sierra Madero J, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man CY, Urbaityte R, Brandon DJ, Underwood M, Pappa KA, Curtis L, Smith KY, Gartland M, Aboud M, van Wyk J, Wynne B. Cahn P, et al. Among authors: hung cc. AIDS. 2022 Jan 1;36(1):39-48. doi: 10.1097/QAD.0000000000003070. AIDS. 2022. PMID: 34534138 Free PMC article. Clinical Trial.
Dolutegravir-rilpivirine coformulation.
Sun HY, Chang SY, Hung CC. Sun HY, et al. Among authors: hung cc. Curr Opin HIV AIDS. 2018 Jul;13(4):320-325. doi: 10.1097/COH.0000000000000466. Curr Opin HIV AIDS. 2018. PMID: 29553948 Review.
Reply.
Huang SH, Yang CJ, Hung CC. Huang SH, et al. Among authors: hung cc. Hepatology. 2020 Feb;71(2):766. doi: 10.1002/hep.30976. Epub 2020 Jan 26. Hepatology. 2020. PMID: 31566772 No abstract available.
HCV Microelimination for High-risk Special Populations.
Huang CF, Chen GJ, Hung CC, Yu ML. Huang CF, et al. Among authors: hung cc. J Infect Dis. 2023 Sep 13;228(Suppl 3):S168-S179. doi: 10.1093/infdis/jiac446. J Infect Dis. 2023. PMID: 37703340 Review.
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Among authors: hung cc. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.
1,288 results